In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

2nd Next Gen Lipid-Based Nanoparticles Delivery

Aug 29, 2023 - 09:00 AM - Aug 31, 04:45 PM
Hanson Wade Group
Boston Park Plaza
50, Park Plz

ZIP: 02116
Phone: (+1) 617 455 4188

Ticket Price: USD 3099.00 - USD 5946.00
2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought leaders in the field all racing to uncover the potential of lipid-delivery properties.

This is your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for extrahepatic delivery.

Providing a complete picture of the lipid-based delivery landscape, from liposomes to LNPs, polymeric lipid nanoparticles, lipid nano-crystals and beyond, join market-leaders to progress your candidates to the clinic applying translatability insights to safeguard payload safety and efficacy.

Join AstraZeneca, Beam Therapeutics, Genentech, BMS and more to expedite the next-generation of lipid-based nanoparticle delivery systems closer to patients this August!

Group discounts and early booking rates are available. Please visit the website for full pricing information.

Tickets: https://go.evvnt.com/1646717-2?pid=1052
Brochure: https://go.evvnt.com/1646717-3?pid=1052

Conference + 3 Workshops - Drug Developer Pricing: USD 5046.00,
Conference + 2 Workshops - Drug Developer Pricing: USD 4397.00,
Conference + 1 Workshop - Drug Developer Pricing: USD 3748.00,
Conference Only - Drug Developer Pricing: USD 3099.00,
Conference + 3 Workshops - Solution Provider Pricing: USD 5946.00,
Conference + 2 Workshops - Solution Provider Pricing: USD 5197.00,
Conference + 1 Workshop - Solution Provider Pricing: USD 4448.00,
Conference Only - Solution Provider Pricing: USD 3699.00

Speaker Details

Ami Jo, Senior Process Engineer, Drug Product Process Development, Omega Therapeutics, Badri Ananthanarayanan, Head of Delivery, EARLI, Bei Cheng, Senior Scientist, AstraZeneca, Daniel Anderson, Professor of Chemical Engineering and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Devyn Smith, Chief Executive Officer, Arbor Biotech, Gaurav Sahay, Associate Professor, Oregan State University, Gulen Yesilbag Tonga, Senior Scientist, Delivery Sciences, Tessera Therapeutics, Haishan Li, Director, Chemistry and Process Development, Hopewell Therapeutics Inc., Hideyoshi Harashima, Professor of Pharmaceutics and the chair of the Laboratory of Molecular Design of Pharmaceutics, Faculty of Pharmaceutical | Hokkaido University, James Ferguson, Chief Medical Officer, Matinas BioPharma, Jeffrey Clogston, Principal Scientist, Physiochemical Characterization Section Head Nanotechnology Characterization, Laboratory, National Cancer Institute, Leidos Biomedical Research, Julie Shi, Associate Director - Scientific, Process Research and Engineering, Bristol Myers Squibb, Justin Cohen, Director, Molecular Discovery, Analytical Conjugation Sciences, Pfizer, Manmohan Singh, Chief Technology Officer, Beam Therapeutics, Mansoor Amiji, University Distinguished Professor, Northeastern University, Manuel Sanchez-Felix, Senior Fellow, Novel Delivery Technologies, Novartis, Niren Murthy, Professor, Department of Bioengineering, University of California, Berkeley, Saikat Manna, Senior Scientist, Delivery and Formulation, Sanofi U.S., Shashi Murthy, Co-Founder and Chief Technology, Officer Nanite, Sriram Sathyanarayanan, Chief Scientific Officer, Codiak Biosciences, Stephan Stern, Laboratory Co-Director, Director of Research and Development, Nanotechnology Characterization Laboratory, National Cancer Institute, Suzanne Saffie-Siebert, Chairwoman and Chief Executive Officer, SiSaf LTD, Theodore Ashburn, President and Chief Executive Officer, Oncorus, Vicent Nebot, Chief Technology Officer and Head of EU, Curapath, Whitney Shatz-Binder, Principal Scientist, Genentech, Yashwant Pathak, Associate Dean Faculty Affairs, University of South Florida

Event Categories
Keywords: Health , Conferences , medicine, science


Events Calendar

30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2

Event Location


VIP Life Time Subscription to our Newsletters!